The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | 14,208 | -22,676 |
| Depreciation and amortization | 6,257 | 12,631 |
| Gains on derivative instruments | 5,808 | 4,371 |
| Stock-based compensation | 706 | 1,474 |
| Amortization of deferred financing fees | 257 | 502 |
| Amortization of debt discount | 202 | 397 |
| Credit loss recovery | -3 | -1 |
| Accounts receivable | -2,700 | -480 |
| Inventory valuation | - | 1,649 |
| Inventories | -2,126 | 5,448 |
| Other assets | -481 | -2,242 |
| Operating leases | -1,703 | -3,180 |
| Accounts payable and accrued liabilities | 5,010 | -2,778 |
| Net cash provided by operating activities | 22,784 | -19,079 |
| Additions to property and equipment | 1,633 | 1,016 |
| Purchase of kodiak carbonic, net of cash acquired | 0 | 7,278 |
| Deferred purchase price payments for eagle alcohol | 0 | 2,240 |
| Net cash used in investing activities | -1,633 | -10,534 |
| Net proceeds from kinergys line of credit | - | 24,520 |
| Net proceeds from (payments on) kinergys line of credit | 6,336 | - |
| Preferred stock dividends paid | 319 | 627 |
| Net cash provided by (used in) financing activities | -18,503 | 23,893 |
| Net change in cash, cash equivalents and restricted cash | 2,648 | -5,720 |
| Cash and cash equivalents at beginning of period | 36,211 | - |
| Cash and cash equivalents at end of period | 33,139 | - |
Alto Ingredients, Inc. (ALTO)
Alto Ingredients, Inc. (ALTO)